AKT1 and Alzheimer disease: BCL2 (BPA logFC −2.59, BPF logFC −1.09, and BPS logFC −1.65), which is involved in the PI3K-AKT signaling pathway, was also found to be common in the three bisphenol exposure groups and was overexpressed in patients with AD [34].